共 67 条
- [1] Norman RJ(2007)Polycystic ovary syndrome Lancet (London, England) 370 685-697
- [2] Dewailly D(2015)Treatment strategies for the infertile polycystic ovary syndrome patient Women’s Health (London, England) 11 901-912
- [3] Legro RS(2017)Polycystic ovary syndrome, adipose tissue and metabolic syndrome Arch Gynecol Obstet 99 725-730
- [4] Tannus S(2013)The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome Fertil Steril 102 767-772
- [5] Burke YZ(1995)Diagnosis, prevention and management of ovarian hyperstimulation syndrome Br J Obstet Gynaecol 28 519-531
- [6] Kol S(2010)Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation Semin Reprod Med 20 242-248
- [7] Delitala AP(2008)In-vitro maturation: its role in fertility treatment Curr Opin Obstet Gynecol 29 513-519
- [8] Capobianco G(2012)Cumulus cell-oocyte complexes retrieved from antral follicles in IVM cycles: relationship between COCs morphology, gonadotropin priming and clinical outcome J Assist Reprod Genet 31 1383-1386
- [9] Delitala G(2016)Clinical definition paper on in vitro maturation of human oocytes Hum Reprod 30 88-96
- [10] Tannus S(2015)In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes Hum Reprod (Oxford, England) 28 1261-1266